Fahri Saatcioglu

  • Researcher
 

Publications 2019

Pällmann N, Livgård M, Tesikova M, Zeynep Nenseth H, Akkus E, Sikkeland J, Jin Y, Koc D, Kuzu OF, Pradhan M, Danielsen HE, Kahraman N, Mokhlis HM, Ozpolat B, Banerjee PP, Uren A, Fazli L, Rennie PS, Jin Y, Saatcioglu F (2019)
Regulation of the unfolded protein response through ATF4 and FAM129A in prostate cancer
Oncogene, 38 (35), 6301-6318
DOI 10.1038/s41388-019-0879-2, PubMed 31312022

Sheng X, Nenseth HZ, Qu S, Kuzu OF, Frahnow T, Simon L, Greene S, Zeng Q, Fazli L, Rennie PS, Mills IG, Danielsen H, Theis F, Patterson JB, Jin Y, Saatcioglu F (2019)
IRE1α-XBP1s pathway promotes prostate cancer by activating c-MYC signaling
Nat Commun, 10 (1), 323
DOI 10.1038/s41467-018-08152-3, PubMed 30679434

Sikkeland J, Lindstad T, Nenseth HZ, Dezitter X, Qu S, Muhumed RM, Ertunc ME, Gregor MF, Saatcioglu F (2019)
Inflammation and ER stress differentially regulate STAMP2 expression and localization in adipocytes
Metabolism, 93, 75-85
DOI 10.1016/j.metabol.2019.01.014, PubMed 30710574

Publications 2018

Winje IM, Sheng X, Hansson KA, Solbrå A, Tennøe S, Saatcioglu F, Bruusgaard JC, Gundersen K (2018)
Cachexia does not induce loss of myonuclei or muscle fibres during xenografted prostate cancer in mice
Acta Physiol (Oxf), 225 (3), e13204
DOI 10.1111/apha.13204, PubMed 30325108

Publications 2017

Jin Y, Nenseth HZ, Saatcioglu F (2017)
Role of PLZF as a tumor suppressor in prostate cancer
Oncotarget, 8 (41), 71317-71324
DOI 10.18632/oncotarget.19813, PubMed 29050363

Urbanucci A, Barfeld SJ, Kytölä V, Itkonen HM, Coleman IM, Vodák D, Sjöblom L, Sheng X, Tolonen T, Minner S, Burdelski C, Kivinummi KK, Kohvakka A, Kregel S, Takhar M, Alshalalfa M, Davicioni E, Erho N, Lloyd P, Karnes RJ, Ross AE, Schaeffer EM, Vander Griend DJ, Knapp S, Corey E et al. (2017)
Androgen Receptor Deregulation Drives Bromodomain-Mediated Chromatin Alterations in Prostate Cancer
Cell Rep, 19 (10), 2045-2059
DOI 10.1016/j.celrep.2017.05.049, PubMed 28591577

Publications 2016

Lindstad T, Qu S, Sikkeland J, Jin Y, Kristian A, Mælandsmo GM, Collas P, Saatcioglu F (2016)
STAMP2 is required for human adipose-derived stem cell differentiation and adipocyte-facilitated prostate cancer growth in vivo
Oncotarget, 8 (54), 91817-91827
DOI 10.18632/oncotarget.11131, PubMed 29190878

Sikkeland J, Sheng X, Jin Y, Saatcioglu F (2016)
STAMPing at the crossroads of normal physiology and disease states
Mol Cell Endocrinol, 425, 26-36
DOI 10.1016/j.mce.2016.02.013, PubMed 26911931

Storm M, Sheng X, Arnoldussen YJ, Saatcioglu F (2016)
Prostate cancer and the unfolded protein response
Oncotarget, 7 (33), 54051-54066
DOI 10.18632/oncotarget.9912, PubMed 27303918

Tesikova M, Dezitter X, Nenseth HZ, Klokk TI, Mueller F, Hager GL, Saatcioglu F (2016)
Divergent Binding and Transactivation by Two Related Steroid Receptors at the Same Response Element
J Biol Chem, 291 (22), 11899-910
DOI 10.1074/jbc.M115.684480, PubMed 27056330

Publications 2015

Jin Y, Wang L, Qu S, Sheng X, Kristian A, Mælandsmo GM, Pällmann N, Yuca E, Tekedereli I, Gorgulu K, Alpay N, Sood A, Lopez-Berestein G, Fazli L, Rennie P, Risberg B, Wæhre H, Danielsen HE, Ozpolat B, Saatcioglu F (2015)
STAMP2 increases oxidative stress and is critical for prostate cancer
EMBO Mol Med, 7 (3), 315-31
DOI 10.15252/emmm.201404181, PubMed 25680860

Sheng X, Arnoldussen YJ, Storm M, Tesikova M, Nenseth HZ, Zhao S, Fazli L, Rennie P, Risberg B, Wæhre H, Danielsen H, Mills IG, Jin Y, Hotamisligil G, Saatcioglu F (2015)
Divergent androgen regulation of unfolded protein response pathways drives prostate cancer
EMBO Mol Med, 7 (6), 788-801
DOI 10.15252/emmm.201404509, PubMed 25864123

Publications 2014

Ertunc ME, Sikkeland J, Fenaroli F, Griffiths G, Daniels MP, Cao H, Saatcioglu F, Hotamisligil GS (2014)
Secretion of fatty acid binding protein aP2 from adipocytes through a nonclassical pathway in response to adipocyte lipase activity
J Lipid Res, 56 (2), 423-34
DOI 10.1194/jlr.M055798, PubMed 25535287

Nenseth HZ, Dezitter X, Tesikova M, Mueller F, Klokk TI, Hager GL, Saatcioglu F (2014)
Distinctly different dynamics and kinetics of two steroid receptors at the same response elements in living cells
PLoS One, 9 (8), e105204
DOI 10.1371/journal.pone.0105204, PubMed 25133404

Sikkeland J, Jin Y, Saatcioglu F (2014)
Methods to assess lipid accumulation in cancer cells
Methods Enzymol, 542, 407-23
DOI 10.1016/B978-0-12-416618-9.00021-2, PubMed 24862278

Publications 2013

Jin Y, Qu S, Tesikova M, Wang L, Kristian A, Mælandsmo GM, Kong H, Zhang T, Jerónimo C, Teixeira MR, Yuca E, Tekedereli I, Gorgulu K, Alpay N, Sood AK, Lopez-Berestein G, Danielsen HE, Ozpolat B, Saatcioglu F (2013)
Molecular circuit involving KLK4 integrates androgen and mTOR signaling in prostate cancer
Proc Natl Acad Sci U S A, 110 (28), E2572-81
DOI 10.1073/pnas.1304318110, PubMed 23798432

Kaarbø M, Storm ML, Qu S, Wæhre H, Risberg B, Danielsen HE, Saatcioglu F (2013)
TCTP is an androgen-regulated gene implicated in prostate cancer
PLoS One, 8 (7), e69398
DOI 10.1371/journal.pone.0069398, PubMed 23894469

Qu S, Olafsrud SM, Meza-Zepeda LA, Saatcioglu F (2013)
Rapid gene expression changes in peripheral blood lymphocytes upon practice of a comprehensive yoga program
PLoS One, 8 (4), e61910
DOI 10.1371/journal.pone.0061910, PubMed 23613970

Sikkeland J, Saatcioglu F (2013)
Differential expression and function of stamp family proteins in adipocyte differentiation
PLoS One, 8 (7), e68249
DOI 10.1371/journal.pone.0068249, PubMed 23874564

Publications 2012

Lazarevic B, Hammarström C, Yang J, Ramberg H, Diep LM, Karlsen SJ, Kucuk O, Saatcioglu F, Taskèn KA, Svindland A (2012)
The effects of short-term genistein intervention on prostate biomarker expression in patients with localised prostate cancer before radical prostatectomy
Br J Nutr, 108 (12), 2138-47
DOI 10.1017/S0007114512000384, PubMed 22397815

ten Freyhaus H, Calay ES, Yalcin A, Vallerie SN, Yang L, Calay ZZ, Saatcioglu F, Hotamisligil GS (2012)
Stamp2 controls macrophage inflammation through nicotinamide adenine dinucleotide phosphate homeostasis and protects against atherosclerosis
Cell Metab, 16 (1), 81-9
DOI 10.1016/j.cmet.2012.05.009, PubMed 22704678

Publications 2011

Lazarevic B, Boezelijn G, Diep LM, Kvernrod K, Ogren O, Ramberg H, Moen A, Wessel N, Berg RE, Egge-Jacobsen W, Hammarstrom C, Svindland A, Kucuk O, Saatcioglu F, Taskèn KA, Karlsen SJ (2011)
Efficacy and safety of short-term genistein intervention in patients with localized prostate cancer prior to radical prostatectomy: a randomized, placebo-controlled, double-blind Phase 2 clinical trial
Nutr Cancer, 63 (6), 889-98
DOI 10.1080/01635581.2011.582221, PubMed 21714686

Varisli L, Gonen-Korkmaz C, Debelec-Butuner B, Erbaykent-Tepedelen B, Muhammed HS, Bogurcu N, Saatcioglu F, Korkmaz KS (2011)
Ubiquitously expressed hematological and neurological expressed 1 downregulates Akt-mediated GSK3β signaling, and its knockdown results in deregulated G2/M transition in prostate cells
DNA Cell Biol, 30 (6), 419-29
DOI 10.1089/dna.2010.1128, PubMed 21323578

Page visits: 3364